PRDM2—The Key Research Targets for the Development of Diseases in Various Systems
Biomolecules · 2025
DOI: 10.3390/biom15081170 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Shiqi Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Athletic Performance, Shanghai University of Sport, Shanghai 200438, China. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Transcription Factors, DNA-Binding Proteins, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Key Laboratory of Human Performance (Shanghai University of sport), Shanghai Oriental Talent Program Youth.
Abstract (Originalsprache)
PR/SET domain 2 (PRDM2)/RIZ is a member of the histone/protein methyltransferases (PRDMs) superfamily. Discovered to have the ability to bind retinoblastoma in the mid-1990s, PRDM2 was assumed to play a role in neuronal development. Like other family members characterized by a conserved N-terminal PR structural domain and a classical C2H2 zinc-finger array at the C-terminus, PRDM2 encodes two major protein types, the RIZ1 and RIZ2 isoforms. The two subtypes differ in the presence or absence of the PR domain: the RIZ1 subtype has the PR domain, whereas the RIZ2 subtype lacks it. The PR domain exhibits varying conservation levels across species and shares structural and functional similarities with the catalytic SET domain, defining histone methyltransferases. Functioning as an SET domain, the PR domain possesses protein-binding interfaces and acts as a lysine methyltransferase. The variable number of classic C2H2 zinc fingers at the C-terminus may mediate protein–protein, protein–RNA, or protein–DNA interactions. An imbalance in the RIZ1/RIZ2 mechanism may be an essential cause of malignant tumors, where PR-positive isoforms are usually lost or downregulated. Conversely, PR-negative isoforms are always present at higher levels in cancer cells. RIZ1 isoforms are also important targets for estradiol interaction with hormone receptors. PRDM2 can regulate gene transcription and expression combined with transcription factors and plays a role in the development of several systemic diseases through mRNA expression deletion, code-shift mutation, chromosomal deletion, and missense mutation occurrence. Thus, PRDM2 is a key indicator for disease diagnosis, but it lacks systematic summaries to serve as a reference for study. Therefore, this paper describes the structure and biological function of PRDM2 from the perspective of its role in various systemic diseases. It also organizes and categorizes its latest research progress to provide a systematic theoretical basis for a more in-depth investigation of the molecular mechanism of PRDM2’s involvement in disease progression and clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Athletic Performance, Shanghai University of Sport, Shanghai 200438, China.
- School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.
Förderung
- National Natural Science Foundation of China
- Shanghai Key Laboratory of Human Performance (Shanghai University of sport)
- Shanghai Oriental Talent Program Youth
Zitieren
APA
Deng, S., Li, H., Zhu, C., Zhang, L., & Zou, J. (2025). PRDM2—The Key Research Targets for the Development of Diseases in Various Systems. Biomolecules. https://doi.org/10.3390/biom15081170
Vancouver
Deng S, Li H, Zhu C, Zhang L, Zou J. PRDM2—The Key Research Targets for the Development of Diseases in Various Systems. Biomolecules. 2025. doi:10.3390/biom15081170
BibTeX
@article{Deng2025,
author = {Deng, Shiqi and Li, Hui and Zhu, Chenyu and Zhang, Lingli and Zou, Jun},
title = {PRDM2—The Key Research Targets for the Development of Diseases in Various Systems},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15081170}
}
EUVIMED